Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Torhout – page 46

2 086 clinical trials in Torhout, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Torhout at a glance
2 086
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 086 trials in Torhout

Open in trial search

Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:OSE Immunotherapeutics

Study on Bezafibrate for Patients with Primary Biliary Cholangitis Not Responding Well to Ursodeoxycholic Acid

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bezafibrate
  • Sponsor:Assistance Publique Hopitaux De Paris

Rectal cancer

Recruiting

Study on Early Erectile Rehabilitation with Sildenafil for Men After Rectal Cancer Surgery

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sildenafil
  • Sponsor:Centre Hospitalier Universitaire Rouen

Long-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Givinostat
  • Sponsor:Italfarmaco S.p.A.

Study of Autologous Cord Blood Stem Cells Treatment for Newborns with Hypoxic-Ischemic Encephalopathy

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Autologous Cord Blood-Derived Mononuclear Cells
  • Sponsor:Assistance Publique Hopitaux De Marseille

Study on Indocyanine Green for Reducing Leakage in Colorectal Cancer Surgery Patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green
  • Sponsor:Centre Hospitalier Regional Universitaire

Study of fluorouracil, irinotecan and oxaliplatin combination therapy for patients with metastatic pancreatic ductal adenocarcinoma who progressed after gemcitabine treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Groupe Belge D'Oncologie Digestive

Study on Post-Surgery Antibiotic Use for Patients with Biliary Stents Undergoing Pancreaticoduodenectomy: Piperacillin and Tazobactam Evaluation

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Piperacillin
  • Sponsor:Centre Hospitalier Universitaire Rouen

Study on Intra-Arterial Thrombolysis with Alteplase for Patients with Acute Ischemic Stroke in the Anterior Circulation

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:CHRU De Nancy

Dermatomyositis

Recruiting

Study on Baricitinib for Patients with Relapsing or Naïve Dermatomyositis

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Baricitinib
  • Sponsor:Assistance Publique Hopitaux De Paris

B-cell lymphoma+1

Recruiting

Study of valemetostat tosylate tablets in patients with relapsed or refractory B-cell lymphoma, including aggressive B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Hodgkin lymphoma

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Valemetostat Tosilate
  • Sponsor:LYSARC

Study of Pioglitazone and Avelumab Combined with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients with Complete Cytogenetic Response

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Centre Hospitalier De Versailles

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Torhout

What the registry says about research in the country

01 Dermatology Research

Innovative clinical research focusing on severe alopecia areata, evaluating a novel oral medication's effectiveness in treating this autoimmune hair loss condition. The trials aim to assess long-term safety and efficacy of different dosing strategies.

  • Hair Loss Treatment
  • Autoimmune Conditions
  • Long-term Treatment Evaluation

Studies include both adult and adolescent participants, exploring various treatment durations and response patterns.

02 Oncology Research

Groundbreaking studies in Non-Small Cell Lung Cancer treatment, comparing therapeutic cancer vaccines with traditional chemotherapy approaches in patients who have undergone prior immunotherapy.

  • Advanced Lung Cancer
  • Immunotherapy
  • Therapeutic Vaccines

Research specifically targets HLA-A2 positive patients with metastatic disease, focusing on survival outcomes.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.